Abstract
Mutations in the SCN8A gene, encoding the voltage-gated sodium channel NaV1.6, are associated with a range of neurodevelopmental syndromes. The p.(Gly1625Arg) (G1625R) mutation was identified in a patient diagnosed with developmental epileptic encephalopathy (DEE). While most of the characterized DEE-associated SCN8A mutations were shown to cause a gain-of-channel function, we show that the G1625R variant, positioned within the S4 segment of domain IV, results in complex effects. Voltage-clamp analyses of NaV1.6G1625R demonstrated a mixture of gain- and loss-of-function properties, including reduced current amplitudes, increased time constant of fast voltage-dependent inactivation, a depolarizing shift in the voltage dependence of activation and inactivation, and increased channel availability with high-frequency repeated depolarization. Current-clamp analyses in transfected cultured neurons revealed that these biophysical properties caused a marked reduction in the number of action potentials when firing was driven by the transfected mutant NaV1.6. Accordingly, computational modeling of mature cortical neurons demonstrated a mild decrease in neuronal firing when mimicking the patients' heterozygous SCN8A expression. Structural modeling of NaV1.6G1625R suggested the formation of a cation-π interaction between R1625 and F1588 within domain IV. Double-mutant cycle analysis revealed that this interaction affects the voltage dependence of inactivation in NaV1.6G1625R. Together, our studies demonstrate that the G1625R variant leads to a complex combination of gain and loss of function biophysical changes that result in an overall mild reduction in neuronal firing, related to the perturbed interaction network within the voltage sensor domain, necessitating personalized multi-tiered analysis for SCN8A mutations for optimal treatment selection.
Original language | English |
---|---|
Article number | 167127 |
Journal | Biochimica et Biophysica Acta - Molecular Basis of Disease |
Volume | 1870 |
Issue number | 5 |
Early online date | 20 Mar 2024 |
DOIs | |
Publication status | Published - Jun 2024 |
Funding
We acknowledge the financial support of The Israel Science Foundation (1454/17, 214/22 to MR, and 1653/21 to YH), The German Research Foundation (DFG Research Unit FOR-2715, grant Le1030/15-2 to HL), The Federal Ministry of Education and Research (BMBF, Treat-ION, 01GM2210A to HL and YL), and The Hartwell Foundation through an Individual Biomedical Research (RBS). Additional support was from The Claire and Amedee Maratier Institute for the Study of Blindness and Visual Disorders, Faculty of Medicine, Tel Aviv University (MR, MG), and The Stolz Foundation Faculty of Medicine, Tel Aviv University (MR), the Kahn Foundation's Orion project, Tel Aviv Sourasky Medical Center, Israel (MG.). The Israel Cancer Research Fund grant 19202 (MG), the Israel Cancer Association grants 20230029 (YH and MG). This work was performed in partial fulfillment of the requirements for a Ph.D. degree of SQ. We also wish to thank Prof. Maya Schuldiner (Weizmann Institute of Science) for introducing us to this project and initiating this fruitful collaboration and Dr. Mahmoud Koko (University of Tuebingen) for his kind help with DNA plasmids and mutagenesis. Publisher Copyright: © 2024 The Authors
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Molecular Biology